Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

Cai, Shuang

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society Sep 2010 - 212-8 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1873-4995

10.1016/j.jconrel.2010.04.006 doi


Animals
Antibiotics, Antineoplastic--administration & dosage
Breast--drug effects
Breast Neoplasms--drug therapy
Cell Line, Tumor
Cell Survival--drug effects
Delayed-Action Preparations--chemistry
Doxorubicin--administration & dosage
Female
Humans
Hyaluronic Acid--chemistry
Rats
Rats, Sprague-Dawley